510(k) Report

510(k) · Cleared

Recalled · 2003

Coaguchek Pro System, Aptt Test Cartridges for Coaguchek Pro System, Aptt Controls for Coaguchek Pro System, Coaguchek P

K983892510(k) TraditionalCleared Apr 13, 1999161-day reviewClass II21 CFR 864.5425Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics/Boehringer Mannheim GmbH · JPA System, Multipurpose For In Vitro Coagulation Studies

Cleared on Apr 13, 1999 as substantially equivalent to K860720 (Biotrack, Inc., 1986) and 2 other predicates after a 161-day review. Its family tree reaches back 1 generation to 1986. It has been recalled once.

Decided
Apr 13, 1999
Review
161 days
Class
Class II
Product code
JPA
Recalls
1
Predicates
3

Its longest line of descent runs back 1 generation to K860720 (1986). 3 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1989: 2 other ancestorsK860720 · Biotrack Monitor (Biotrack Reagent Cartridges) · Biotrack, Inc. · 19861985199019952000
Other ancestors, by generation 1 generation back: 2 other ancestors K860720 · Biotrack Monitor (Biotrack Reagent Cartridges) · Biotrack, Inc. · 19860
  1. Root · 1 generation backK860720 Biotrack Monitor (Biotrack Reagent Cartridges)Biotrack, Inc. · 1986
  2. This deviceK983892 Coaguchek Pro System, Aptt Test Cartridges for Coaguchek Pro System…Roche Diagnostics/Boehringer Mannheim GmbH · 1999
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K860720Biotrack Monitor (Biotrack Reagent Cartridges)Biotrack, Inc.1986—
0 (this device)K983892Coaguchek Pro System, Aptt Test Cartridges for Coaguchek Pro System, Aptt…Roche Diagnostics/Boehringer Mannheim GmbH1999—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198920
FIG. 1 — Lineage of K983892, 1986–1999Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JPA device

  1. #1 K243858 TEG 6s Hemostasis System Citrated: K, KH, RT…score 12.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K860720Biotrack Monitor (Biotrack Reagent Cartridges)
Summary page 1
…lassification name: Multipurpose system for in vitro coagulation studies We claim substantial equivalence to the Biotrack monitor and APTT test cartridges and controls, K860720, K890052, K890051. The Biotrack system is also known as the Roche Diagnostics CoaguChek Plus System, APTT test and controls. Con…
Biotrack, Inc.1986—
*K890052Biotrack Aptt Reagent Cartridge
Summary page 1
…tion name: Multipurpose system for in vitro coagulation studies We claim substantial equivalence to the Biotrack monitor and APTT test cartridges and controls, K860720, K890052, K890051. The Biotrack system is also known as the Roche Diagnostics CoaguChek Plus System, APTT test and controls. Continued on…
Biotrack, Inc.1989—
*K890051Biotrack Aptt Controls
Summary page 1
…: Multipurpose system for in vitro coagulation studies We claim substantial equivalence to the Biotrack monitor and APTT test cartridges and controls, K860720, K890052, K890051. The Biotrack system is also known as the Roche Diagnostics CoaguChek Plus System, APTT test and controls. Continued on next pag…
Biotrack, Inc.1989—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Mar 12, 2003Not classifiedZ-0813-03OtherHigh frequency signals from other medical or communications equipment will result in a variable positive bias in test results.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 3 ancestors has a recall.

How does its category compare?

All JPA devices

JPA System, Multipurpose For In Vitro Coagulation Studies: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JPA

3in 2025

2007: 12008: 22009: 62010: 12011: 12013: 12015: 22016: 62017: 42018: 12019: 32021: 12022: 12023: 32024: 12025: 32026 (partial year): 1
2007high 6 (2009) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JPA

30in 2025

2009: 91 days median2016: 114 days median2017: 117 days median2019: 175 days median2023: 506 days median2025: 30 days median
2007high 506 (2023) · low 30 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JPA

1in 2020

2007: 12010: 62011: 42012: 12016: 32020: 12026 (partial year): 1
2007high 6 (2010) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JPA

11in 2025

2007: 1,7442008: 9182009: 1,3632010: 7272011: 1612012: 522013: 432014: 482015: 452016: 62017: 152018: 392019: 272020: 182021: 72022: 92023: 112024: 82025: 11
2007high 1,744 (2007) · low 6 (2016)2025

MAUDE reports naming product code JPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—11,744
20082—0918
200969101,363
20101—6727
20111—4161
20120—152
20131—043
20140—048
20152—045
2016611436
20174117015
20181—039
20193175027
20200—118
20211—07
20221—09
20233506011
20241—08
2025330011
20261—1—

What is it indicated for?

The CoaguChek Pro APTT test is for the quantitative determination of the activated partical thromboplastin time (APTT) of freshly drawn whole blood. It is intended for health care professional use only.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K983892: Coaguchek Pro System, Aptt Test Cartridges for Coaguchek Pro System, Aptt Controls for Coaguchek Pro System, Coaguchek P.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K983892

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026